e-Newsletter – September 2022
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Search results
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
jCyte have released additional preclinical data regarding jCell
In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.
SalioGen Developing Novel Gene Insertion Therapy for Stargardt disease.
Be a souper-star and raise funds whilst having lunch for #TeamRetinaUK
Lynda Cantor was a founder member of the charity in 1975 and one of our original trustees
Our monthly e-Newsletter featuring the latest updates from Retina UK.
A new approach to treating inherited sight loss
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
An American living with Leber congenital amaurosis 10 (LCA10) has become the first clinical trial participant in the world to receive a CRISPR gene editing treatment in vivo (inside the body).